GE to Sell Its Biotech Business to Danaher for $21 Billion

GE agreed to sell its biotechnology business to Danaher for $21 billion in cash, moving to pay down debt by parting with one of its fastest growing businesses.

from WSJ.com: US Business https://ift.tt/2tEAl5m
via IFTTT